Stocks News

LAST PRICE
372.0000
TODAY'S CHANGE (%)
Trending Down-2.3200 (-0.6198%)

Bid / Lots
360.0100/ 1
Ask / Lots
595.3600/ 2
Open / Previous Close
375.5000 / 374.3200
Day Range
Low 368.3700
High 377.8550
52 Week Range
Low 185.4300
High 419.4200
Volume
221,668
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 3, 2024
- DJ S&P 500 Futures Fall In Premarket Trading; On Holding, Blue Owl Capital Lead, from 7:31AM ET on Wednesday Apr 03, 2024 by Dow Jones
  7:31AM ET on Wednesday Apr 03, 2024 by Dow Jones
  Companies Mentioned: FLR, INTC, UHAL, MEDP, NFE, OWL, ONON
  
  This article was automatically generated by Barrons.com using technology from Automated Insights.
  
  With U.S. stock markets set to open in two hours, On Holding AG (ONON) was up 5.7% in pre-market trading, and Blue Owl Capital Inc. (OWL) was up 3.7%.
Mar 28, 2024
- Press Release: Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024, from 4:28PM ET on Thursday Mar 28, 2024 by Dow Jones
  4:28PM ET on Thursday Mar 28, 2024 by Dow Jones
  Companies Mentioned: MEDP
  
  Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
  CINCINNATI--(BUSINESS WIRE)--March 28, 2024--
  Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results.
- Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024, from 4:05PM ET on Thursday Mar 28, 2024 by Business Wire
  4:05PM ET on Thursday Mar 28, 2024 by Business Wire
  Companies Mentioned: MEDP
  Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results.
- Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024, from 4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
  4:05PM ET on Thursday Mar 28, 2024 by Dow Jones
  Companies Mentioned: MEDP
  CINCINNATI--(BUSINESS WIRE)--March 28, 2024--
  Medpace Holdings, Inc. (Nasdaq: MEDP) ("Medpace") today announced that it will report its first quarter 2024 financial results after the market close on Monday, April 22, 2024. The Company will host a conference call the following morning, Tuesday, April 23, 2024, at 9:00 a.m. ET to discuss these results.
Mar 23, 2024
- DJ U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ, from 9:00AM ET on Saturday Mar 23, 2024 by Dow Jones
  9:00AM ET on Saturday Mar 23, 2024 by Dow Jones
  Companies Mentioned: IOVA, LLY, NVO, TMO, MEDP, VIR, CTLT, CRL
  
  By David Wainer
  
  Earlier this week, as the U.S. government said Intel was getting billions of dollars in grants as part of the Chips Act, some drug-industry representatives couldn't help but feel a twinge of envy.

Yesterday
- United Therapeutics Insider Sold Shares Worth $1,704,990, According to a Recent SEC Filing, from 14 hours ago by MT Newswires
  14 hours ago by MT Newswires
  Companies Mentioned: UTHR
Apr 17, 2024
- United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing, from 4:40PM ET on Wednesday Apr 17, 2024 by MT Newswires
  4:40PM ET on Wednesday Apr 17, 2024 by MT Newswires
  Companies Mentioned: UTHR
Apr 16, 2024
- Neurocrine Biosciences, Sentia Medical Sciences Extend Partnership on Prospective Drug Development, from 4:32PM ET on Tuesday Apr 16, 2024 by MT Newswires
  4:32PM ET on Tuesday Apr 16, 2024 by MT Newswires
  Companies Mentioned: NBIX
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Tuesday Apr 16, 2024 by Business Wire
  7:00AM ET on Tuesday Apr 16, 2024 by Business Wire
  Companies Mentioned: UTHR
Apr 15, 2024
- United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing, from 4:37PM ET on Monday Apr 15, 2024 by MT Newswires
  4:37PM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: UTHR
- Sector Update: Health Care Stocks Advance Premarket Monday, from 9:14AM ET on Monday Apr 15, 2024 by MT Newswires
  9:14AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: EXAS, IBB, XLV, RARE, NMRA
- Exact Sciences Names Aaron Bloomer CFO, from 8:12AM ET on Monday Apr 15, 2024 by MT Newswires
  8:12AM ET on Monday Apr 15, 2024 by MT Newswires
  Companies Mentioned: EXAS
Apr 11, 2024
- United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing, from 4:36PM ET on Thursday Apr 11, 2024 by MT Newswires
  4:36PM ET on Thursday Apr 11, 2024 by MT Newswires
  Companies Mentioned: UTHR
- Exact Sciences Signs Debt Exchange Deal, Placement of Convertible Notes, from 10:31AM ET on Thursday Apr 11, 2024 by MT Newswires
  10:31AM ET on Thursday Apr 11, 2024 by MT Newswires
  Companies Mentioned: EXAS
Apr 9, 2024
- United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing, from 4:40PM ET on Tuesday Apr 09, 2024 by MT Newswires
  4:40PM ET on Tuesday Apr 09, 2024 by MT Newswires
  Companies Mentioned: UTHR

Medpace Holdings Inc
NASDAQ:MEDPUnited States

Search Criteria

Apr 3, 2024

DJ S&P 500 Futures Fall In Premarket Trading; On Holding, Blue Owl Capital Lead, from 7:31AM ET on Wednesday Apr 03, 2024 by Dow Jones

Mar 28, 2024

Press Release: Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024, from 4:28PM ET on Thursday Mar 28, 2024 by Dow Jones

Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024, from 4:05PM ET on Thursday Mar 28, 2024 by Business Wire

Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024, from 4:05PM ET on Thursday Mar 28, 2024 by Dow Jones

Mar 23, 2024

DJ U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street -- WSJ, from 9:00AM ET on Saturday Mar 23, 2024 by Dow Jones

Peers Headlines

Yesterday

United Therapeutics Insider Sold Shares Worth $1,704,990, According to a Recent SEC Filing, from 14 hours ago by MT Newswires

Apr 17, 2024

United Therapeutics Insider Sold Shares Worth $1,682,819, According to a Recent SEC Filing, from 4:40PM ET on Wednesday Apr 17, 2024 by MT Newswires

Apr 16, 2024

Neurocrine Biosciences, Sentia Medical Sciences Extend Partnership on Prospective Drug Development, from 4:32PM ET on Tuesday Apr 16, 2024 by MT Newswires

United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2024 International Conference, from 7:00AM ET on Tuesday Apr 16, 2024 by Business Wire

Apr 15, 2024

United Therapeutics Insider Sold Shares Worth $1,707,775, According to a Recent SEC Filing, from 4:37PM ET on Monday Apr 15, 2024 by MT Newswires

Sector Update: Health Care Stocks Advance Premarket Monday, from 9:14AM ET on Monday Apr 15, 2024 by MT Newswires

Exact Sciences Names Aaron Bloomer CFO, from 8:12AM ET on Monday Apr 15, 2024 by MT Newswires

Apr 11, 2024

United Therapeutics Insider Sold Shares Worth $6,831,737, According to a Recent SEC Filing, from 4:36PM ET on Thursday Apr 11, 2024 by MT Newswires

Exact Sciences Signs Debt Exchange Deal, Placement of Convertible Notes, from 10:31AM ET on Thursday Apr 11, 2024 by MT Newswires

Apr 9, 2024

United Therapeutics Insider Sold Shares Worth $4,727,736, According to a Recent SEC Filing, from 4:40PM ET on Tuesday Apr 09, 2024 by MT Newswires